caprylic acid
Caprylic acid, also known under the systematic name octanoic acid or C8 Acid, is a saturated fatty acid, medium-chain fatty acid (MCFA). It has the structural formula H3C−(CH2)6−COOH, and is a colorless oily liquid that is minimally soluble in water with a slightly unpleasant rancid-like smell and taste. Salts and esters of octanoic acid are known as octanoates or caprylates. The name of the related acyl group is octanoyl, capryloyl, or caprylyl. It is a common industrial chemical, which is produced by oxidation of the C8 aldehyde. Its compounds are found naturally in the milk of various mammals and as a minor constituent of coconut oil and palm kernel oil. — Wikipedia
Clinical trial activity
8 trials · 5 clinical orgs · 0 marketing orgs
Earliest trial started Jul 1, 2016 (NCT02833012)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCaprylic acid ↗
Also known as
- ac-1202
- ac-1202
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05628636 | Phase 1 | Nov 14, 2022 | Cerecin |
| NCT05408780 | Phase 1 | Jul 14, 2022 | Cerecin |
| NCT05028114 | Phase 1 | Aug 31, 2021 | Cerecin |
| NCT03635879 | Phase 1 | Feb 13, 2019 | Cerecin |
| NCT03904433 | N/A | Aug 24, 2018 | Karolinska Institute |
| NCT04253704 | Phase 1/Phase 2 (Phase 2) | Feb 13, 2017 | Cantor Research Laboratory, Sytheon Ltd. |
| NCT02959710 | Phase 1 | Nov 1, 2016 | Celerion, Cerecin |
| NCT02833012 | Phase 1 | Jul 1, 2016 | Celerion, Cerecin |
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cerecin | For profit | 6 | 6 | 1 | 2016 |
| Celerion | For profit | 2 | 0 | 1 | 2016 |
| Cantor Research Laboratory | For profit | 1 | 0 | 1 | 2017 |
| Karolinska Institute | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Sytheon Ltd. | For profit | 1 | 1 | 1 | 2017 |